A Double-blind Trial of Lactobacillus paracasei Strain KW3110 Administration for Immunomodulation in Patients with Pollen Allergy
Background:Lactobacillus paracasei strain KW3110 has been shown by in vitro cytokine secretion analysis to be a potent Th1 inducer and Th2 repressor. Oral administration of L. paracasei strain KW3110 also represses IgE elevation in the ovalbumin sensitized mouse allergy model. Methods:During pollen...
Saved in:
Published in: | Allergology International Vol. 54; no. 1; pp. 143 - 149 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | Japanese |
Published: |
JAPANESE SOCIETY OF ALLERGOLOGY
2005
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background:Lactobacillus paracasei strain KW3110 has been shown by in vitro cytokine secretion analysis to be a potent Th1 inducer and Th2 repressor. Oral administration of L. paracasei strain KW3110 also represses IgE elevation in the ovalbumin sensitized mouse allergy model. Methods:During pollen season from January to April in 2003, a daily dose of 4x1010 cfu L. paracasei strain KW3110 was fed for 12 weeks as a yogurt to 14 pollen allergy patients(mean age 39.0 years). A yogurt made with Lactobacillus delbrueckii strain B, shown to be a poor Th1 inducer and Th2 repressor in a former study, was also fed at a daily dose of 4x1010 cfu for 12 weeks to 14 pollen allergy patients(mean age, 39.0 years). Blood samples were collected every 4 weeks. Eosinophils, eosinophil cationic protein (ECP), non-specific serum IgE, cedar pollen specific serum IgE, and Th1/Th2 ratios were quantified. Results:Twelve weeks after ingestion of the yogurts, the group that was fed L. delbrueckii group showed significant reductions in the Th1/Th2 ratios between the first observation in January and last observation in April, representing the four month study period, due to increases in Th2 cells. Significant increases in ECP were also observed in the group fed L. delbrueckii between January and April. In contrast, the group fed L. paracasei had no significant changes in the ECP and Th1/Th2 ratios. Conclusions:Our results suggest that ingestion of the L. paracasei strain KW3110 is associated with both repression of Th2 cell generation and eosinophil activation. Our data point to the possibility that specific lactic acid bacteria may be useful for allergy therapy. |
---|---|
AbstractList | Background:Lactobacillus paracasei strain KW3110 has been shown by in vitro cytokine secretion analysis to be a potent Th1 inducer and Th2 repressor. Oral administration of L. paracasei strain KW3110 also represses IgE elevation in the ovalbumin sensitized mouse allergy model. Methods:During pollen season from January to April in 2003, a daily dose of 4x1010 cfu L. paracasei strain KW3110 was fed for 12 weeks as a yogurt to 14 pollen allergy patients(mean age 39.0 years). A yogurt made with Lactobacillus delbrueckii strain B, shown to be a poor Th1 inducer and Th2 repressor in a former study, was also fed at a daily dose of 4x1010 cfu for 12 weeks to 14 pollen allergy patients(mean age, 39.0 years). Blood samples were collected every 4 weeks. Eosinophils, eosinophil cationic protein (ECP), non-specific serum IgE, cedar pollen specific serum IgE, and Th1/Th2 ratios were quantified. Results:Twelve weeks after ingestion of the yogurts, the group that was fed L. delbrueckii group showed significant reductions in the Th1/Th2 ratios between the first observation in January and last observation in April, representing the four month study period, due to increases in Th2 cells. Significant increases in ECP were also observed in the group fed L. delbrueckii between January and April. In contrast, the group fed L. paracasei had no significant changes in the ECP and Th1/Th2 ratios. Conclusions:Our results suggest that ingestion of the L. paracasei strain KW3110 is associated with both repression of Th2 cell generation and eosinophil activation. Our data point to the possibility that specific lactic acid bacteria may be useful for allergy therapy. |
Author | Hiroyuki Watanabe Hisakazu Iino Satoshi Nishida Hideyuki Wakabayashi Daisuke Fujiwara |
Author_xml | – sequence: 1 fullname: Daisuke Fujiwara – sequence: 2 fullname: Hideyuki Wakabayashi – sequence: 3 fullname: Hiroyuki Watanabe – sequence: 4 fullname: Satoshi Nishida – sequence: 5 fullname: Hisakazu Iino |
BookMark | eNotUF1LxDAQzMMJnuf9h_yBQj7b5rGceh4WPPDEx7JJU42kiTQth4_-cyMn7M4OwzLL7A1ahRjsCq0pZ7yoFSfXaJuS00SIitVK8TX6afBdXLS3hfYu9Pg0OfA4DrgFM0cNxnm_JPwFExhI1uGXeQIX8NMbp5Tgph9dcClrs4sBD3HCh3FcQhxjv_iLmLePmdkwJ3x28wc-Ru9twE3G6f37Fl0N4JPd_s8Nen24P-0ei_Z5f9g1bTFSUpOC91SqCpRRwkpuykprIzMXOcagbSWYLE0JoCrGhAUhBm60FCWtwAo59HyD9hff0fbOgI8hB7bdZ1ymkO925iwgK3PHCJFdbkFoRxjpCBX8D1Su_DbJfwFg3miU |
ContentType | Journal Article |
CorporateAuthor | Central Laboratories for Key Technology Koiwai Dairy Products Co Showa Women's University Japan Kirin Brewery Co Ltd Kanagawa Department of Science for Living System Technical Development Center |
CorporateAuthor_xml | – name: Technical Development Center – name: Ltd – name: Koiwai Dairy Products Co – name: Kirin Brewery Co – name: Central Laboratories for Key Technology – name: Kanagawa – name: Japan – name: Showa Women's University – name: Department of Science for Living System |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | 149 |
ExternalDocumentID | cw4alint_2005_005401_020_0143_01491497285 |
GroupedDBID | --- .55 0R~ 0SF 1OC 23M 2WC 31~ 4.4 457 53G 5GY 5VS 7.U 8-1 AACTN AAEDW AAIKJ AALRI AAXUO ABMAC ACGFO ACGFS ACXQS ADBBV ADEZE ADVLN AENEX AEXQZ AFTJW AFZJQ AGHFR AITUG AJAOE AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ AZFZN BAWUL BCNDV BFHJK CAG CO8 COF CS3 DIK E3Z EBS EJD F5P FDB FRJ GROUPED_DOAJ GX1 HZ~ IPNFZ JSF JSH KQ8 LH4 LW6 M41 NCXOZ O9- OK1 P2P P6G RIG RJT RNS ROL RZJ SSZ TKC TR2 X7M YFH YUY |
ID | FETCH-LOGICAL-m1080-3d1597a9c94e53c67bbc594e4993fbe74256c6aa97224ea44f3cb54617ae45fd3 |
ISSN | 1323-8930 |
IngestDate | Fri Nov 08 06:50:30 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-m1080-3d1597a9c94e53c67bbc594e4993fbe74256c6aa97224ea44f3cb54617ae45fd3 |
PageCount | 7 |
ParticipantIDs | medicalonline_journals_cw4alint_2005_005401_020_0143_01491497285 |
PublicationCentury | 2000 |
PublicationDate | 20050000 |
PublicationDateYYYYMMDD | 2005-01-01 |
PublicationDate_xml | – year: 2005 text: 20050000 |
PublicationDecade | 2000 |
PublicationTitle | Allergology International |
PublicationYear | 2005 |
Publisher | JAPANESE SOCIETY OF ALLERGOLOGY |
Publisher_xml | – name: JAPANESE SOCIETY OF ALLERGOLOGY |
SSID | ssib044728993 ssib050995378 ssj0012797 ssib001508366 |
Score | 1.7382315 |
Snippet | Background:Lactobacillus paracasei strain KW3110 has been shown by in vitro cytokine secretion analysis to be a potent Th1 inducer and Th2 repressor. Oral... |
SourceID | medicalonline |
SourceType | Publisher |
StartPage | 143 |
Title | A Double-blind Trial of Lactobacillus paracasei Strain KW3110 Administration for Immunomodulation in Patients with Pollen Allergy |
URI | http://mol.medicalonline.jp/library/journal/abstract?GoodsID=cw4alint/2005/005401/020&name=0143-0149e |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Li9swEBbpHkpLKX3Sbh_o0JsxJJYU27c1rbdZul1Ck7LtyUi2XLyb2JDELHvsP--MpfiR05ZSMMLIxmDPZ803I-kbQj5k4yBUIUtd4ELcBX_MXDXW2hVSeyEwdu4pzHfMFv7Fj-BTzOPRaF8yquv7r5aGPrA17pz9C2u3D4UOOAebQwtWh_ZOdo-QE6uVdhUQyMxZNlU5momAFP_dtFit6q2Dit8pOLACp6VlUTpfLhm46AMt3WYN4hnuIKnWVWYLfWGGZG7UWO3WuDkmH0onwl2FvwbTxKbLyDwNco9dgrzY4vqQ0_qquJGb1kfMikzf1teFcymvpZK3WPKpu7ap7DVgtlK10FzIXQX3AbqhtZmGfUJD9NzMPLqIFzGKQJzFy5-47ik6P4-_fe7m1MwozTzmAtEa94dxo0U9gKsZkydGB8q694lRSD0Q2U5vOIQ95Q6rcoqk4bGTBJh0gvKH2IRw-F6AagYQcQe92N3wThT5bnkd5z7Gse3AB6QsFMzvprc831T92b_HQ_JobebljD5Kj-Isn5DHNjahkQHVUzK6ks_I_a929cVz8juifWzRBlu0yukAW7TFFjXYogZbdIgtCtiih9iicPceWxSxRQ22qMXWC_L9NF5-nLm2hIe7xsWrLsuALvsyTEOuBUunvlKpgHOIs1mutA8eY5pOpYRv63EtOc9ZqgQHWi01F3nGXpKjsir1K0I5dE0EcDqRK86zXHmBArYvuQC_5GXea3Iy-IaJ_Sm3yZ2Ne_zvj3hDHjTivk2S7i052m1q_Y7c22b1-wYyfwAflZsW |
link.rule.ids | 315,782,786,4028 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Double-blind+Trial+of+Lactobacillus+paracasei+Strain+KW3110+Administration+for+Immunomodulation+in+Patients+with+Pollen+Allergy&rft.jtitle=Allergology+International&rft.au=Daisuke+Fujiwara&rft.au=Hideyuki+Wakabayashi&rft.au=Hiroyuki+Watanabe&rft.au=Satoshi+Nishida&rft.date=2005&rft.pub=JAPANESE+SOCIETY+OF+ALLERGOLOGY&rft.issn=1323-8930&rft.volume=54&rft.issue=1&rft.spage=143&rft.epage=149&rft.externalDocID=cw4alint_2005_005401_020_0143_01491497285 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1323-8930&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1323-8930&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1323-8930&client=summon |